Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

Clinical trial NCT06463626 · COMPLETED

Trial details

NCT number: NCT06463626
Sponsor: Novartis
Status: COMPLETED
Study type: OBSERVATIONAL

Hormone-receptor-positive Breast Cancer Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Start date: 2020-04-06
Primary completion: 2023-06-27
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.